Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Options may include SGLT2 inhibitors, metformin, thiazolidinediones, or insulin for diabetes, noting that DPP-4 inhibitors also carry pancreatitis warnings
Patient Suitability: Who Should Avoid or Exercise Caution
Many systemic inflammatory conditions have gastrointestinal components that benefit from this approach
It is also used for metabolic syndrome such as prediabetes, weight loss, dyslipidemia due to its lipid-lowering effect, polycystic ovary syndrome, and other health conditions
Clinical trial data show it helps 37% of people lose at least 5% of their starting body weight in 12 weeks
The comparison group taking a placebo lost only 2.9% of their weight, on average
US$ 25.45
US$ 27.44
US$ 28.11
